CABASER Cabergoline 2mg tablet bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

cabaser cabergoline 2mg tablet bottle

pfizer australia pty ltd - cabergoline, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose; leucine - for the management of the signs and symptoms of parkinson's disease. treatment should be initiated under specialist supervision. the benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy( see contraindications, precautions and adverse effects)

CABASER Cabergoline 1mg tablet bottle Australia - englanti - Department of Health (Therapeutic Goods Administration)

cabaser cabergoline 1mg tablet bottle

pfizer australia pty ltd - cabergoline, quantity: 1 mg - tablet, uncoated - excipient ingredients: leucine; lactose - for the management of the signs and symptoms of parkinson's disease. treatment should be initiated under specialist supervision. the benefit of continued treatment should be regularly reassessed taking into account the risk of fibrotic reactions and valvulopathy( see contraindications, precautions and adverse effects)

Octreoscan 111 MBq/mL, kit for radiopharmaceutical preparation Irlanti - englanti - HPRA (Health Products Regulatory Authority)

octreoscan 111 mbq/ml, kit for radiopharmaceutical preparation

curium netherlands b.v. - indium (111 in) chloride solution; pentetreotide - kit for radiopharmaceutical preparation - 111 megabecquerel(s)/millilitre - indium (111in) pentetic acid

Endoscopic electrosurgical electrode, bipolar, single-use Australia - englanti - Department of Health (Therapeutic Goods Administration)

endoscopic electrosurgical electrode, bipolar, single-use

grc surgical pty ltd - 61872 - endoscopic electrosurgical electrode, bipolar, single-use - the lina bipolar loop is a 5mm bipolar electrosurgical device intended for amputating the mobilized uterus during laparoscopic supracervical (subtotal) hysterectomy and resection of devasculated subserosal pedunculated myomas. to be used with an electrosurgical generator.

DOSTINEX Israel - englanti - Ministry of Health

dostinex

pfizer pfe pharmaceuticals israel ltd - cabergoline - tablets - cabergoline 0.5 mg - cabergoline - cabergoline - treatment of hyperprolactinemic disorders.dostinex is indicated for the treatment of dysfunctions associated with hyperprolactinemia, including amenorrhea, oligomenorrhea, anovulation and galactorrhea. dostinex is indicated in patients with prolactin-secreting pituitary adenomas (micro-and macroprolactinomas), idiopathic hyperprolactinemia, or empty sella syndrome with associated hyperprolactinemia. inhibition and supression of lactation .